MarketScreener Homepage > Equities > Korea Stock Exchange > Hansae Yes24 Holdings Co., Ltd A016450 KR7016450009

Report

End-of-day quote Korea Stock Exchange - 01/25
7610	KRW		0.00%

2020

HANSA BIOPHARMA : Biopharma to present at the 39th Annual J.P. Morgan Healthcare Conference

2020

HANSA BIOPHARMA : Nomination Committee formed

2020

Hansa Biopharma interim report Jan-Sep 2020

Summary

Quotes 5-day view End-of-day quote.

End-of-day quote Korea Stock Exchange

01/19/2021	01/20/2021	01/21/2021	01/22/2021	01/25/2021	Date
7180	7380	7440	7610	7610	Last
346773	113324	62778	115983	58281	Volume
+3.31%	+2.79%	+0.81%	+2.28%	0.00%	Change

Financials

Sales 2020	2 794 B 2,53 B 2,53 B
Net income 2020	- - -
Net Debt 2020	439 B 0,40 B 0,40 B
P/E ratio 2020	-
Yield 2020	3,29%

Sales 2021	2 821 B 2,56 B 2,56 B
Net income 2021	- - -
Net Debt 2021	423 B 0,38 B 0,38 B
P/E ratio 2021	-
Yield 2021	3,29%

Capitalization	299 B 271 M 271 M
EV / Sales 2020	0,26x
EV / Sales 2021	0,26x
Nbr of Employees	15
Free-Float	18,2%

More Financials

Company

HANSAE YES24 HOLDINGS is a Korea-based holding company engaged in the management of its subsidiaries. The Companyâ€™s subsidiaries include HANSAE CO., LTD., engaged in the original equipment manufacturing (OEM), wholesale, import and export of knit shirts, ladies wears and casual clothing and YES24 CO., LTD, engaged in Internet shopping mall business, which provides books, records, digital versatile discs (DVDs),...

Sector

Apparel & Accessories

Calendar

02/16

Ergebnisveröffentlichung

More about the company

All news about HANSAE YES24 HOLDINGS CO., LTD

2020	HANSA BIOPHARMA : Biopharma to present at the 39th Annual J.P. Morgan Healthcar..	AQ
2020	HANSA BIOPHARMA : Nomination Committee formed	AQ
2020	Hansa Biopharma interim report Jan-Sep 2020	AQ
2020	HANSA BIOPHARMA : Biopharm announces positive high-level data from investigator-..	AQ
2020	HANSA BIOPHARMA : Biopharma to host Capital Markets Day on Thursday October 29,..	AQ
2020	HANSA BIOPHARMA : certified as a Great Place to Work	AQ
2020	HANSA BIOPHARMA : provides updated guidance on its clinical programs	AQ
2020	HANSA BIOPHARMA : announces participation in Fall conferences and an updated fin..	AQ
2020	HANSA BIOPHARMA PUBL : announces increase in number of shares and votes	AQ
2020	HANSA BIOPHARMA PUBL : expands the leadership team with the appointment of Katja..	AQ
2020	Hansa Biopharma interim report Jan-Jun 2020	AQ
2020	HANSA BIOPHARMA PUBL : announces successful completion of SEK 1.1bn (USD 121m) p..	AQ
2020	HANSA BIOPHARMA PUBL : announces intention to carry out a placing of new ordinar..	AQ
2020	Hansa Biopharma announces exclusive agreement with Sarepta Therapeutics to de..	AQ
2020	HANSA BIOPHARMA PUBL : to host conference call to provide interim results for th..	AQ

More news

News in other languages on HANSAE YES24 HOLDINGS CO., LTD

- No features available -

More news

Chart HANSAE YES24 HOLDINGS CO., LTD

Duration : Period :

Hansae Yes24 Holdings Co., Ltd Technical Analysis Chart | MarketScreener

Full-screen chart

Income Statement Evolution

More Financials

Consensus

Sell

Buy

Mean consensus	OUTPERFORM
Number of Analysts	1
Average target price	8 000,00 KRW
Last Close Price	7 610,00 KRW
Spread / Highest target	5,12%
Spread / Average Target	5,12%
Spread / Lowest Target	5,12%

Consensus

Managers and Directors

Name	Title
Dong-Nyung Kim	Chairman & Co-Chief Executive Officer
Seok-Hwan Kim	Co-Chief Executive Officer & Director
Gil-Song Lee	Independent Director
Jong-Jae Lee	Independent Director
Chan-Geun Lee	Independent Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

HANSAE YES24 HOLDINGS CO., LTD	-0.65%	271



LVMH MOËT HENNESSY - LOUIS VUITTON SE	-1.76%	306 374
LULULEMON ATHLETICA INC.	-2.31%	44 314
VF CORPORATION	-1.81%	33 076
LI NING COMPANY LIMITED	-3.85%	16 351
MONCLER S.P.A.	-5.58%	14 511

More Results